UNSPSC 42321714: Acetabular augments

In this classification, this commodity indicates a product used as an acetabular augment in a surgical procedure in a medical setting. US FDA regulates Acetabular augments under 21 CFR 888.3588 and under FDA product code LPH. Most nations, for tariff and trade purposes, schedule these products under HS 902129.

UNSPSC 42321714 Acetabular augments is a Commodity code that covers orthopedic surgical implants and related extraction or removal systems used in hospitals and surgical centers. Recent state and local solicitations show purchasing focused on orthopedic hardware removal and extraction services for acute-care hospital environments, as well as broader medical-supplies master agreements that bundle acetabular augments alongside other device categories. Issuing bodies include public hospital systems, state departments, cooperative purchasing vehicles (Sourcewell and NASPO ValuePoint), and county health authorities. The work being solicited ranges from capital equipment procurement to ongoing as-needed service contracts with technical support and logistics components.

Recent activity shows San Mateo Medical Center (San Mateo County, California) soliciting on-call orthopedic hardware removal and extraction system services under RFP 666002526252 with a July 1, 2026 response date and three-year contract term; NASPO ValuePoint administering a multi-state cooperative-purchasing master-agreement RFP (26RFP1433, due November 9, 2026) for medical supplies open to state and local entities across multiple jurisdictions; and Sourcewell (Minnesota local government cooperative) requesting proposals for physical health products and related services (26RFP102026, due October 20, 2026) to establish a contracting vehicle for participating entities. A separate California procurement (RFBIS27200016, bid July 28, 2026) for outpatient-building furniture indicates that some codes tagged to acetabular augments reflect broader facility procurement rather than implant-specific purchasing. The most substantive orthopedic-implant activity appears concentrated in California, with cooperative purchasing vehicles and state health agencies also active. The absence of multiple standalone acetabular-augment device procurements suggests the code is often bundled into larger medical-supplies or orthopedic-services contracts rather than solicited as a discrete commodity.